Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation

Transpl Int. 2014 Jul;27(7):674-85. doi: 10.1111/tri.12321. Epub 2014 Apr 25.

Abstract

Serial monitoring of peripheral blood lymphocyte subpopulations (PBLSs) counts might be useful in predicting post-transplant opportunistic infection (OI) after kidney transplantation (KT). PBLSs were prospectively measured in 304 KT recipients at baseline and post-transplant months 1 and 6. Areas under receiver operating characteristic curves were used to evaluate the accuracy of different subpopulations in predicting the occurrence of overall OI and, specifically, cytomegalovirus (CMV) disease. We separately analyzed patients not receiving (n = 164) or receiving (n = 140) antithymocyte globulin (ATG) as induction therapy. In the non-ATG group, a CD8(+) T-cell count at month 1 <0.100 × 10(3) cells/μl had negative predictive values of 0.84 and 0.86 for the subsequent occurrence of overall OI and CMV disease, respectively. In the multivariate Cox model, a CD8(+) T-cell count <0.100 × 10(3) cells/μl was an independent risk factor for OI (adjusted hazard ratio: 3.55; P-value = 0.002). In the ATG group, a CD4(+) T-cell count at month 1 <0.050 × 10(3) cells/μl showed negative predictive values of 0.92 for the subsequent occurrence of overall OI and CMV disease. PBLSs monitoring effectively identify KT recipients at low risk of OI, providing an opportunity for individualizing post-transplant prophylaxis practices.

Keywords: cytomegalovirus; kidney transplantation; lymphocytopenia; monitoring; opportunistic infection; peripheral blood lymphocyte subpopulations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antilymphocyte Serum / therapeutic use
  • CD4 Lymphocyte Count
  • CD8-Positive T-Lymphocytes
  • Cytomegalovirus Infections / immunology
  • Humans
  • Kidney Transplantation / adverse effects*
  • Lymphocyte Count
  • Lymphocyte Subsets*
  • Middle Aged
  • Opportunistic Infections / immunology*
  • Predictive Value of Tests
  • Prospective Studies
  • Risk Factors

Substances

  • Antilymphocyte Serum